Literature DB >> 11738393

Biochemical profile and survival in nonagenarians.

D Solichova1, B Melichar, V Blaha, M Klejna, J Vavrova, V Palicka, Z Zadak.   

Abstract

OBJECTIVES: Old age is associated with an increase in frequency of disorders involving virtually all organ systems, resulting in a rise of mortality. The aim of the project was to study the relationship between biochemical markers and all-cause mortality in a defined age group. DESIGN AND METHODS: Thirty-eight nonagenarians, aged 92 +/- 2 (range 90-100) years entered the study. At the start of the study, a sample of peripheral blood and urine were obtained for analysis of 50 basic biochemical, hematologic and biologic parameters. The assessment was then repeated in 6 to 12 months intervals. The significance of difference between surviving subjects and those who died was examined by Mann-Whitney U test and the correlation between the variables was studied by Spearman rank correlation coefficient.
RESULTS: During the observation period, 21 of the studied subjects died leaving 17 persons still alive at the end of the study. The mean time from the first measurement to the death was 12 +/- 10 (range 0-33) months. The mean follow-up time in surviving subjects was 31 +/- 12 (range 4-45) months. Serum vitamin E and calcium were significantly higher, and serum alanine aminotransferase (ALT) and urinary neopterin were significantly lower in survivors compared to the subjects who died. No other parameters were significantly different in survivors and in persons who died. Urinary neopterin exhibited a significant negative correlation with serum sodium concentration (RS = -0.50, p < 0.01), but the other parameters did not correlate significantly.
CONCLUSION: In conclusion, among the parameters studied, differences between survivors and nonsurvivors were observed only for serum vitamin E, calcium, ALT and urinary neopterin. These findings may form a basis for prospective interventional trials in this group of patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738393     DOI: 10.1016/s0009-9120(01)00261-2

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  10 in total

1.  Association of detectable cytomegalovirus (CMV) DNA in monocytes rather than positive CMV IgG serology with elevated neopterin levels in community-dwelling older adults.

Authors:  Sean X Leng; Huifen Li; Qian-Li Xue; Jing Tian; Xi Yang; Luigi Ferrucci; Neal Fedarko; Linda P Fried; Richard D Semba
Journal:  Exp Gerontol       Date:  2011-04-13       Impact factor: 4.032

2.  Neopterin, a Marker of Interferon-Gamma-Inducible Inflammation, Correlates with Pyridoxal-5'-Phosphate, Waist Circumference, HDL-Cholesterol, Insulin Resistance and Mortality Risk in Adult Boston Community Dwellers of Puerto Rican Origin.

Authors:  G Oxenkrug; K L Tucker; P Requintina; P Summergrad
Journal:  Am J Neuroprot Neuroregen       Date:  2011-06

Review 3.  Neopterin as a biomarker of immune response in cancer patients.

Authors:  Bohuslav Melichar; Martina Spisarová; Marie Bartoušková; Lenka Kujovská Krčmová; Lenka Javorská; Hana Študentová
Journal:  Ann Transl Med       Date:  2017-07

Review 4.  Disturbed tryptophan metabolism in cardiovascular disease.

Authors:  H Mangge; I Stelzer; E Z Reininghaus; D Weghuber; T T Postolache; D Fuchs
Journal:  Curr Med Chem       Date:  2014-06       Impact factor: 4.530

5.  Frailty, inflammation, and immunity.

Authors:  Huifen Li; Bhavish Manwani; Sean X Leng
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

6.  Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders.

Authors:  Gregory F Oxenkrug
Journal:  J Neural Transm (Vienna)       Date:  2010-09-02       Impact factor: 3.575

7.  IL-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adults.

Authors:  Sean X Leng; Xinping Tian; Amy Matteini; Huifen Li; Jennifer Hughes; Alka Jain; Jeremy D Walston; Neal S Fedarko
Journal:  Age Ageing       Date:  2011-05-17       Impact factor: 10.668

8.  Risk factors of atherosclerosis during systemic therapy targeting vascular endothelial growth factor.

Authors:  Hana Študentová; Jarmila Indráková; Pavla Petrová; Milan Kamínek; Hana Kalábová; Vlastislav Šrámek; Tomáš Adam; Bohuslav Melichar
Journal:  Oncol Lett       Date:  2015-12-09       Impact factor: 2.967

9.  Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients.

Authors:  J Víšek; M Bláha; V Bláha; M Lášticová; M Lánska; C Andrýs; J Duintjer Tebbens; Ivone Cristina Igreja E Sá; K Tripská; M Vicen; I Najmanová; P Nachtigal
Journal:  Orphanet J Rare Dis       Date:  2021-02-27       Impact factor: 4.123

10.  Multiplex Protein Biomarker Profiling in Patients with Familial Hypercholesterolemia.

Authors:  Dana Dlouha; Milan Blaha; Eva Rohlova; Jaroslav A Hubacek; Vera Lanska; Jakub Visek; Vladimir Blaha
Journal:  Genes (Basel)       Date:  2021-10-12       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.